| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.34 | 5e-11 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.3 | 8e-11 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-10 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.28 | 9e-09 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-08 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-08 |